22 Nov 2016
(MENAFN) UAE-based Julphar Gulf Pharmaceutical Industries has reported sales revenue of USD290.2mn in the Jan-Sep period of this year.
Furthermore, the firm posted gross revenue of USD169.5mn and its net profit for the period was USD42.8mn.
Accordingly, the Saudi and UAE markets contributed 56 percent of the sales for the cited period, while the growth in the MENA markets has been slow for the period.
In recent challenging environment, the firm’s management has taken steps to reduce cost, like Opex Control to enhance profitability.
31 Aug 2025
BBK announces an exceptional 6-month grace period financing campaign for Personal and Car Finance customers
13 Aug 2025
BBK’s BD 5,000,000 Al Hayrat scheme awards BD 680,000 to 390 Al Hayrat winners in August and September
04 Aug 2025
HM the King’s Support for Youth is an Inspirational Model for Their Empowerment Journey
28 Jul 2025
BBK discloses its financial results for the half year ended 30th June 2025
20 Jul 2025
CBB approves the transfer of the retail banking operations of HSBC Bank Middle East, Bahrain Branch to BBK
08 Jul 2025
BBK proudly launches the third edition of “Grow” and welcomes 20 Bahraini graduates
03 Jul 2025
BBK hosts executive leadership session on digital assets in collaboration with Rain
02 Jul 2025
BBK launches the largest-ever Al Hayrat Prizes, offering BD 5 million to over 2,000 winners
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more